We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Purdue Pleads Guilty to Mislabeling OxyContin
Purdue Pleads Guilty to Mislabeling OxyContin
May 10, 2007
Purdue Pharma and three current and former company executives pleaded guilty to mislabeling OxyContin and will pay more than $634 million in fines, according to a U.S. prosecutor.